In February, The FDA approved the Argus II, the first retinal implant to enable blind patients with retinitis pigmentosa to see. The implant was produced by Second Sight, a medical products company,  which has been implanted in about seventy blind patients so far. Second Sight was founded by Alfred Mann, a biomedical entrepreneur who also founded Advanced Bionics, a company specializing in cochlear implants for deaf patients.